MedPageToday

(MedPage Today) -- BOSTON -- Investigational crinecerfont reduced the need for glucocorticoids in adults and kids with congenital adrenal hyperplasia (CAH), two phase III trials found. In the adult trial of 182 patients, those on crinecerfont...

(MedPage Today) -- "It feels like we're being asked to see more and more patients in less and less time." -- Meghan Lelonek, MD, a hospitalist with Sound Physicians and PeaceHealth in Washington, who helped lead a unionization effort. "School...

(MedPage Today) -- CHICAGO -- Patients without disease progression following chemoradiotherapy for unresectable stage III non-small cell lung cancer (NSCLC) should receive osimertinib (Tagrisso) if they harbor EGFR mutations, experts said here...

(MedPage Today) -- CHICAGO -- Preoperative intralesional treatment with a dual antibody-cytokine fusion significantly improved relapse-free survival (RFS) in locally advanced melanoma versus surgery alone, a randomized trial showed. Median RFS...

(MedPage Today) -- CHICAGO -- Progression-free survival (PFS) was significantly higher with belantamab mafodotin (belamaf; Blenrep) combined with pomalidomide (Pomalyst) and dexamethasone (BPd), compared with standard-of-care pomalidomide, bortezomib...

(MedPage Today) -- CHICAGO -- Early palliative care delivered via video was as effective as in-person visits on quality-of-life (QoL) measures among patients with advanced lung cancer, according to the REACH-PC trial. Further, patient and caregiver...

(MedPage Today) -- Sunday, 7 a.m.: On any given Sunday morning, I expect to arrive for my emergency department (ED) shift to a department in disarray. There's a certain colliding of worlds that happens -- the wreckage of Saturday night debauchery...

(MedPage Today) -- CHICAGO -- Treatment with single-agent sacituzumab govitecan (Trodelvy) offered no survival advantage over docetaxel in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy...

(MedPage Today) -- CHICAGO -- Subcutaneous amivantamab (Rybrevant) was non-inferior to IV amivantamab for pre-treated patients with refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC), with the suggestion of a possible survival...

(MedPage Today) -- CHICAGO -- An investigational bispecific antibody targeting PD-1 and VEGF significantly decreased the risk of disease progression or death in patients with metastatic EGFR-mutant non-small cell lung cancer (NSCLC) who progressed...

(MedPage Today) -- CHICAGO -- Replacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced classical Hodgkin lymphoma (cHL) with no loss in efficacy, according to a randomized study reported. The estimated 4...

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center...

(MedPage Today) -- Nurses are critical to a functioning healthcare system, yet our country is currently facing a nursing shortage that is projected to intensify in the next few years. The shortage is not just a statistic for me; it is a reality...

(MedPage Today) -- Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up were higher than expected, but the vaccine's benefits still outweigh any small potential risk, according...